Point72 Asset Management
JBIO

Point72 Asset Management’s Jade Biosciences JBIO Stock Holding History

Point72 Asset Management’s Portfolio JBIO Stock Details JBIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$3.71M Sell
264,315
-294,159
-53% -$4.26M ﹤0.01% 1903
2025
Q4 		$8.62M Buy
+558,474
New +$6.55M 0.01% 1449
2024
Q2 		– Sell
-11,424
Closed -$11.8M – 1857
2024
Q1 		$11.8M Sell
11,424
-1,190
-9% -$909K 0.03% 655
2023
Q4 		$9.99M Buy
+12,614
New +$6.43M 0.02% 686
2023
Q2 		– Sell
-1,975
Closed -$1.39M – 2170
2023
Q1 		$1.39M Sell
1,975
-3,026
-61% -$2.51M ﹤0.01% 1050
2022
Q4 		$5.13M Buy
+5,001
New +$3.63M 0.02% 749
2021
Q4 		– Sell
-1,539
Closed -$1.13M – 1085
2021
Q3 		$1.13M Buy
+1,539
New +$862K 0.01% 842

Other funds holding JBIO

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
FFM
Fairmount Funds Management West Conshohocken, Pennsylvania $1.38B AUM 407.79% 1-Year Est. Return
APM
Avidity Partners Management Dallas, Texas $936M AUM 195% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
VA
VR Adviser New York $2.68B AUM 422.73% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

Point72 Asset Management's JBIO Position: Q1 2026 in Review

Point72 Asset Management reduced its Jade Biosciences (JBIO) stake by 53% in Q1 2026, selling an estimated $4.26M and leaving 264,315 shares worth $3.71M. The position accounts for ﹤0.01% of the portfolio, ranked #1903.

Point72 Asset Management first reported a position in JBIO in Q3 2021 and has held it in 7 quarters since. The position peaked at $11.8M in Q1 2024. 120 funds tracked by Wall St. Rank hold JBIO as of Q1 2026.

  • Point72 Asset Management held 264,315 shares of Jade Biosciences worth $3.71M as of Q1 2026.
  • Point72 Asset Management sold 294,159 Jade Biosciences shares in Q1 2026, an estimated $4.26M.
  • Jade Biosciences made up ﹤0.01% of Point72 Asset Management's portfolio in Q1 2026, its #1903 holding.
  • Point72 Asset Management first reported a position in Jade Biosciences in Q3 2021 and has held it in 7 quarters since.
  • Point72 Asset Management's Jade Biosciences position peaked at $11.8M in Q1 2024.
  • 120 funds tracked by Wall St. Rank held Jade Biosciences as of Q1 2026.

Based on Point72 Asset Management's 13F filing for Q1 2026, filed 15 May 2026.